Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions.

Resolution of acute inflammation is an active process orchestrated by endogenous mediators and mechanisms pivotal in host defense and homeostasis. The macrophage mediator in resolving inflammation, maresin 1 (MaR1), is a potent immunoresolvent, stimulating resolution of acute inflammation and organ protection. Using an unbiased screening of greater than 200 GPCRs, we identified MaR1 as a stereoselective activator for human leucine-rich repeat containing G protein-coupled receptor 6 (LGR6), expressed in phagocytes. MaR1 specificity for recombinant human LGR6 activation was established using reporter cells expressing LGR6 and functional impedance sensing. MaR1-specific binding to LGR6 was confirmed using 3H-labeled MaR1. With human and mouse phagocytes, MaR1 (0.01-10 nM) enhanced phagocytosis, efferocytosis, and phosphorylation of a panel of proteins including the ERK and cAMP response element-binding protein. These MaR1 actions were significantly amplified with LGR6 overexpression and diminished by gene silencing in phagocytes. Thus, we provide evidence for MaR1 as an endogenous activator of human LGR6 and a novel role of LGR6 in stimulating MaR1's key proresolving functions of phagocytes.

[1]  J. Cha,et al.  A maresin 1/ROR&agr;/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis , 2019, The Journal of clinical investigation.

[2]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[3]  D. Gilroy,et al.  Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli–driven acute inflammation , 2018, JCI insight.

[4]  Zhi-jun Zhang,et al.  GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain , 2018, The Journal of clinical investigation.

[5]  K. Sakamoto,et al.  The Role of the Transcription Factor CREB in Immune Function , 2010, The Journal of Immunology.

[6]  G. Fredman.  DELineating resolution of inflammation , 2018, Nature Immunology.

[7]  Joachim Wegener,et al.  Electrical wound-healing assay for cells in vitro. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Shubhada Sankararaman,et al.  Cells, tissues and disease: Principles of general pathology , 1997 .

[9]  K. Akassoglou,et al.  Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders , 2018, British journal of anaesthesia.

[10]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[11]  M. Spite,et al.  Resolving inflammation in nonalcoholic steatohepatitis. , 2019, The Journal of clinical investigation.

[12]  M. Delano,et al.  The immune system's role in sepsis progression, resolution, and long‐term outcome , 2016, Immunological reviews.

[13]  C. Tabin,et al.  Lgr6 marks nail stem cells and is required for digit tip regeneration , 2015, Proceedings of the National Academy of Sciences.

[14]  C. Serhan,et al.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. , 2017, Molecular aspects of medicine.

[15]  J. Schwab,et al.  Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury , 2017, The Journal of Neuroscience.

[16]  Clay W Scott,et al.  Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity , 2009, Journal of biomolecular screening.

[17]  R. Rekha,et al.  Prostaglandin E2 suppresses hCAP18/LL‐37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  J. Markworth,et al.  Divergent shifts in lipid mediator profile following supplementation with n‐3 docosapentaenoic acid and eicosapentaenoic acid , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  C. Serhan,et al.  Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages , 2014, PloS one.

[20]  M. Perretti,et al.  Immune resolution mechanisms in inflammatory arthritis , 2017, Nature Reviews Rheumatology.

[21]  C. Serhan,et al.  Diversity of lipid mediators in human adipose tissue depots. , 2013, American journal of physiology. Cell physiology.

[22]  J. Wallace,et al.  Gaseous mediators in resolution of inflammation. , 2015, Seminars in immunology.

[23]  Single-cell mass cytometry of TCR signaling: Amplification of small initial differences results in low ERK activation in NOD mice , 2014, Proceedings of the National Academy of Sciences.

[24]  C. Serhan,et al.  Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.

[26]  C. Serhan,et al.  Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. , 2017, Molecular aspects of medicine.

[27]  A. Granholm,et al.  Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis , 2015, Molecular Neurobiology.

[28]  P. J. van der Spek,et al.  The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. , 2000, Molecular endocrinology.

[29]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[30]  S. Narumiya,et al.  International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress , 2011, Pharmacological Reviews.

[31]  Trevor A. Mori,et al.  Specialised pro-resolving mediators of inflammation in inflammatory arthritis. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.

[32]  Takao Shimizu,et al.  A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.

[33]  P. Briss,et al.  Health Care Industry Insights: Why the Use of Preventive Services Is Still Low , 2019, Preventing chronic disease.

[34]  S. Miscia,et al.  Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins , 2015, Stem cells translational medicine.

[35]  D. Romberger,et al.  Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust. , 2015, Translational research : the journal of laboratory and clinical medicine.

[36]  Takao Shimizu,et al.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. , 2009, Annual review of pharmacology and toxicology.

[37]  Gunnar Rätsch,et al.  Prediction of ultra-potent shRNAs with a sequential classification algorithm , 2017, Nature Biotechnology.

[38]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[39]  Hans Clevers,et al.  Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.

[40]  H. Clevers,et al.  Lgr6 Marks Stem Cells in the Hair Follicle That Generate All Cell Lineages of the Skin , 2010, Science.

[41]  Q. Lin,et al.  LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor , 2012, PloS one.

[42]  D. Gilroy,et al.  Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP , 2008, Blood.

[43]  C. Serhan,et al.  Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation , 2016, The Journal of Immunology.

[44]  Brian C Lewandowski,et al.  Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo , 2014, Proceedings of the National Academy of Sciences.

[45]  C. Serhan,et al.  Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. , 2015, Biochimica et biophysica acta.

[46]  C. Serhan,et al.  A cluster of immunoresolvents links coagulation to innate host defense in human blood , 2017, Science Signaling.

[47]  Christof Fellmann,et al.  An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.

[48]  C. Serhan,et al.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.

[49]  H. Kayserili,et al.  RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6 , 2018, Nature.

[50]  B. Spur,et al.  Total synthesis of the macrophage derived anti-inflammatory lipid mediator Maresin 1 , 2012 .

[51]  C. Serhan,et al.  New maresin conjugates in tissue regeneration pathway counters leukotriene D4–stimulated vascular responses , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.